Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",22452,175,1.55 [1.04-2.30],0.0301036563535757
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23477,184,2.05 [1.43-2.93],9.46820446369865e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",23235,1399,1.45 [1.25-1.67],4.044898597629355e-07
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Candidiasis,23489,370,1.72 [1.32-2.25],6.81344776367038e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,22806,3437,1.35 [1.23-1.48],2.9608623215877045e-10
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),22764,3471,1.55 [1.41-1.70],4.301052595940151e-20
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,23281,1040,1.49 [1.26-1.76],2.703077069849929e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,23415,79,2.22 [1.32-3.73],0.0025609147719971
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,21276,1107,1.66 [1.41-1.97],1.9874311460842043e-09
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,20536,1229,1.85 [1.59-2.17],1.1062054937139724e-14
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,20253,246,2.44 [1.74-3.41],1.994196267952845e-07
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,16522,2257,1.56 [1.39-1.74],5.42183556725148e-14
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,20186,402,1.77 [1.34-2.32],4.420664552714299e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23479,1238,1.51 [1.30-1.76],8.61020060711371e-08
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Mycoses,23577,458,1.59 [1.24-2.03],0.0002121682215232
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,22723,887,1.57 [1.32-1.87],5.713257234969116e-07
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23498,1221,1.49 [1.28-1.73],3.089514419770884e-07
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22427,186,2.03 [1.42-2.89],9.606355404334364e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,23616,53,1.56 [0.75-3.22],0.2322150114956824
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,23344,1067,1.54 [1.31-1.81],1.5920125637552825e-07
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23403,67,2.04 [1.12-3.72],0.0200828657041058
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23555,120,2.02 [1.29-3.17],0.0022370987716058
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23534,99,1.87 [1.13-3.12],0.0156507793140271
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22321,485,1.84 [1.47-2.31],1.2302152694479977e-07
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,22120,284,1.19 [0.86-1.65],0.283530789307318
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,22329,88,2.16 [1.30-3.59],0.0031005133670685
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,23597,67,2.06 [1.10-3.86],0.0235203416980553
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23561,143,1.01 [0.63-1.61],0.9757911578038152
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Viral warts,23471,53,0.98 [0.45-2.11],0.9503671803189498
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],23469,51,0.77 [0.35-1.69],0.5143970092860899
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Benign lipomatous neoplasm,23303,343,0.97 [0.72-1.32],0.8601329587607661
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23544,45,0.42 [0.18-0.97],0.0416002111316385
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23511,55,0.58 [0.27-1.24],0.1582237810298966
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,23567,131,1.10 [0.68-1.80],0.69115938469691
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",23242,1623,1.06 [0.93-1.22],0.3756446679366584
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Benign neoplasm of meninges,23617,32,0.59 [0.22-1.62],0.3076923750509034
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23554,64,1.73 [0.90-3.33],0.1030342607846715
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,23600,72,1.20 [0.63-2.28],0.5853441794586784
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Benign neoplasm: Ascending colon,23591,433,0.92 [0.70-1.20],0.5237733395618211
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Benign neoplasm: Caecum,23586,337,1.20 [0.89-1.62],0.2320900097383483
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23486,81,1.22 [0.66-2.24],0.5280406369604442
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Benign neoplasm: Descending colon,23583,269,0.96 [0.69-1.35],0.8336637165940318
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Benign neoplasm: Rectum,23542,420,1.09 [0.83-1.43],0.5348827699584939
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23496,732,1.09 [0.89-1.34],0.4232317979470407
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Benign neoplasm: Transverse colon,23571,554,1.27 [1.01-1.60],0.0395321512643945
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",18344,71,1.58 [0.83-2.99],0.1639338117298501
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",18343,70,1.99 [1.08-3.69],0.0278332729542841
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23584,100,1.25 [0.72-2.17],0.4200745536446747
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Haemangioma, any site",23584,97,1.22 [0.70-2.14],0.4820700948552071
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Lung cancer and mesothelioma,15718,343,1.11 [0.81-1.51],0.5310246841507871
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Lymphoid leukaemia,18338,65,1.53 [0.78-3.00],0.2189901740450891
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",18466,193,1.52 [1.02-2.24],0.0379946090819297
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",18561,288,1.15 [0.83-1.59],0.4163269616163334
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",18364,91,1.60 [0.93-2.74],0.0863946389903216
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",18412,139,1.91 [1.24-2.94],0.0034393687438903
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",18412,139,1.08 [0.67-1.73],0.7571525165141562
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",18355,82,1.25 [0.68-2.28],0.4778040580211147
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",19676,1403,0.99 [0.85-1.15],0.8485297771262212
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",18416,143,0.79 [0.49-1.27],0.3261361436096023
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",18380,107,1.22 [0.72-2.08],0.4585921442741835
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,18402,129,1.23 [0.75-2.01],0.4159868507324736
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Melanocytic naevi,23493,171,1.25 [0.82-1.91],0.3025226362616263
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Melanocytic naevi of trunk,23586,95,1.83 [1.07-3.15],0.0285491962173903
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Melanoma in situ,18305,72,1.12 [0.58-2.18],0.731001190710059
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",18373,100,1.91 [1.13-3.22],0.0149651613452085
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",18440,167,1.61 [1.06-2.43],0.0252491862699451
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",18491,218,0.91 [0.62-1.34],0.6332106224698844
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",18373,100,1.57 [0.92-2.69],0.0997773577081916
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Other benign neoplasms of skin,23485,135,1.22 [0.76-1.96],0.4154341291287943
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",19466,1193,0.99 [0.84-1.17],0.8926897981098764
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",19539,1266,1.00 [0.85-1.17],0.9855871004568764
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23344,307,1.63 [1.20-2.20],0.001606288798887
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,21892,118,3.79 [2.86-5.02],2.525546130722045e-20
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,23108,71,1.26 [0.66-2.40],0.490694116413736
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,23063,2758,1.66 [1.50-1.83],7.116311731365428e-23
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,22356,62,1.97 [1.03-3.74],0.0394074636756643
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,23193,50,2.49 [1.31-4.73],0.0052414258832467
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,23237,1463,1.62 [1.42-1.86],3.2957387813136175e-12
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,23235,1461,1.62 [1.42-1.86],3.557381336917884e-12
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,21878,104,2.19 [1.37-3.49],0.0010103747257409
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23378,1084,1.88 [1.61-2.19],9.633380249317582e-16
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,23246,103,1.95 [1.18-3.22],0.0092622357626803
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,23110,73,1.72 [0.94-3.13],0.0771873871620439
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,23099,62,0.70 [0.34-1.45],0.3399563426020606
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,23454,311,2.16 [1.65-2.83],2.2593334109468185e-08
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,23523,48,3.10 [1.62-5.91],0.0005981774159125
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",23397,254,2.29 [1.71-3.06],2.6252209986028585e-08
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,22370,76,1.59 [0.89-2.85],0.1183130984972494
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,17402,375,2.64 [2.01-3.46],2.0354917647885786e-12
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,21594,163,0.70 [0.45-1.10],0.1201845792235561
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,21620,189,0.88 [0.58-1.33],0.5377852204155082
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,17081,54,2.06 [0.97-4.35],0.05990003121783
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,22249,65,1.86 [0.97-3.56],0.0627218946866045
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,21496,221,1.16 [0.80-1.70],0.426169803234682
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",23115,614,1.57 [1.27-1.95],3.054225957043386e-05
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,22742,241,1.25 [0.88-1.78],0.2148942141106735
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,22669,168,1.10 [0.71-1.68],0.6772702363699854
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,23314,1130,1.45 [1.23-1.70],7.358343789927164e-06
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,20201,1087,1.43 [1.21-1.68],3.2378438113725624e-05
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",17101,74,1.88 [1.00-3.52],0.0490775043332638
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",22751,38,1.67 [0.71-3.92],0.2365310869190871
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,17297,270,1.48 [1.05-2.09],0.024284478023524
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,17099,72,2.55 [1.36-4.79],0.0036638370985705
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,20873,3846,1.03 [0.94-1.13],0.5075230288874664
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,17211,184,1.51 [1.00-2.29],0.0492395054324165
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,17589,562,1.37 [1.08-1.73],0.0101565825586665
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23559,274,1.59 [1.16-2.19],0.0039937690019124
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,23374,89,2.97 [1.95-4.53],3.9939361853965705e-07
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,17178,151,1.07 [0.67-1.70],0.7852317155332168
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",17092,65,3.30 [1.82-5.98],8.000708035378601e-05
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,23448,735,1.84 [1.52-2.22],2.6119236115198086e-10
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,17335,308,3.01 [2.27-3.99],2.5089109935892013e-14
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,17406,379,3.14 [2.44-4.04],4.601860841733611e-19
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",17746,719,1.14 [0.93-1.41],0.2163555942488817
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,17171,144,2.85 [1.88-4.31],7.38695447673204e-07
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,23367,82,3.03 [1.98-4.66],3.737640967069709e-07
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,17594,567,2.01 [1.60-2.53],2.71802032830929e-09
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,17420,393,1.59 [1.20-2.11],0.0012212118328618
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,21342,67,1.47 [0.75-2.87],0.2637444468667073
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,22186,5159,1.12 [1.03-1.21],0.0059810253092016
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,22733,20,3.34 [1.43-7.77],0.0051913651712596
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,22735,22,1.31 [0.41-4.16],0.6488412984556009
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,23444,1757,1.15 [1.01-1.31],0.0405223838435405
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",23442,1754,1.14 [1.00-1.30],0.0561903266517948
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,22735,22,4.34 [1.92-9.80],0.0004072356483923
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,23349,798,1.11 [0.91-1.35],0.3183022489999849
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",18644,1617,1.90 [1.66-2.18],1.9545402666081726e-20
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,23605,267,3.53 [2.88-4.32],3.5720589029573267e-34
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,22609,108,1.28 [0.76-2.16],0.3503311204132528
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,22627,76,1.39 [0.74-2.62],0.3045743280757104
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,22632,81,1.21 [0.66-2.21],0.5428372822930863
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",17090,63,1.44 [0.71-2.93],0.3100348627618021
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,20859,165,3.16 [2.42-4.13],3.55335984654006e-17
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2479,123,4.04 [2.86-5.69],1.9090049295554906e-15
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2636,313,2.32 [1.79-3.01],2.552252875408677e-10
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,20792,98,2.86 [2.14-3.83],1.5497264414054285e-12
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2435,81,15.49 [9.07-26.43],9.583622263514988e-24
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,22833,2139,1.55 [1.39-1.73],1.1057591006732035e-14
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,22858,357,1.34 [1.01-1.79],0.0438547093681684
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,21513,238,1.60 [1.13-2.28],0.0080277048106965
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,17818,791,1.77 [1.45-2.15],1.3876935992499861e-08
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23493,250,1.41 [1.00-1.98],0.0482995335827687
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),22403,274,1.36 [0.98-1.89],0.0693533375614674
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Angina pectoris,20716,1479,1.15 [0.99-1.33],0.0590977864574317
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Aortic aneurysm,22511,382,1.04 [0.78-1.38],0.7991409657381552
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,22212,83,2.01 [1.16-3.51],0.0132864617258669
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",22371,242,2.22 [1.64-3.00],1.9864986341621338e-07
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,13828,2294,1.29 [1.15-1.46],2.4464995899152423e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,AV-block,19000,617,1.64 [1.34-2.00],1.3165034842329442e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23541,541,1.22 [0.96-1.55],0.0974445858861291
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Cardiac arrest,11783,249,1.95 [1.35-2.81],0.0003706834597156
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,18581,198,1.60 [1.10-2.34],0.0149660575060329
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",18491,108,1.87 [1.14-3.06],0.0125999041726052
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,23618,67,1.97 [1.14-3.41],0.0157486744842889
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Conduction disorders,19731,1348,1.43 [1.24-1.65],7.9763032954283e-07
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,21818,2605,1.10 [0.99-1.23],0.0755473655829232
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,19882,7689,1.10 [1.03-1.18],0.0029752440659839
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,22397,274,1.38 [1.00-1.92],0.0503389789151096
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Endocarditis,18464,81,1.03 [0.56-1.89],0.9344439564609832
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",23306,1310,1.51 [1.31-1.74],1.5214033235532344e-08
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Hypertension,21069,6706,1.15 [1.07-1.23],6.985516055787929e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",21091,6728,1.16 [1.08-1.24],3.086812672649263e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,"Hypertension, portal",23386,110,3.30 [2.36-4.60],2.321215900788848e-12
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",14545,182,2.47 [1.69-3.61],3.1569396741679712e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,14532,169,5.70 [4.27-7.61],3.0005058230962383e-32
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Hypotension,23473,1229,1.64 [1.41-1.92],3.1818552860235377e-10
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,22552,117,0.81 [0.48-1.37],0.4360216649598202
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",21960,2723,1.09 [0.98-1.21],0.1188645232431277
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23187,648,1.28 [1.03-1.59],0.0238137064330779
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Left bundle-branch block,18795,412,1.28 [0.98-1.66],0.0686405125157805
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,22888,1057,1.18 [0.99-1.40],0.0572834057087465
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",20152,915,1.26 [1.05-1.51],0.0147159829044792
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23456,222,0.98 [0.68-1.43],0.9350192177844946
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",23565,371,1.38 [1.04-1.83],0.0241706202445225
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Oesophageal varices,22191,68,2.60 [1.61-4.20],9.065742043904668e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Other aneurysm,22225,96,1.10 [0.62-1.94],0.7497298918757502
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Other arrhythmias,18861,478,1.48 [1.16-1.89],0.0017585156866683
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,22261,132,2.00 [1.29-3.11],0.002133371906646
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,22411,282,1.99 [1.48-2.68],5.357402918007508e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,18574,191,1.22 [0.82-1.83],0.3208238167754242
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Other disorders of veins,22220,97,1.47 [0.87-2.50],0.1494067132357686
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,22174,51,1.83 [0.88-3.80],0.1069535265935666
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,22038,90,1.38 [0.79-2.42],0.2549839993462221
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,22227,104,1.26 [0.75-2.12],0.3780257471513469
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,19624,1241,1.34 [1.16-1.56],0.0001276902637496
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,22308,64,3.55 [2.05-6.12],5.542385576507141e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,22693,564,2.02 [1.64-2.49],3.733462896131848e-11
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,22980,363,1.62 [1.25-2.12],0.0003370208190223
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",22615,667,1.50 [1.22-1.84],0.0001279249387392
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,11910,376,1.72 [1.28-2.31],0.0003181752299863
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,22604,521,2.14 [1.74-2.62],2.825584457513462e-13
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22478,355,1.30 [0.97-1.73],0.0771166151173312
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,23110,493,0.82 [0.64-1.06],0.1269917260997466
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23555,708,1.31 [1.07-1.60],0.0089022535401455
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Right bundle-branch block,18850,467,1.71 [1.35-2.15],6.0316441696713935e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,22978,361,1.57 [1.20-2.05],0.0010031258446533
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,22170,222,1.98 [1.42-2.77],6.399874594934978e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23171,736,1.21 [0.99-1.48],0.06700178118162
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23156,765,1.23 [1.01-1.50],0.0400888745932671
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,22530,47,1.38 [0.62-3.07],0.4318997458186632
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,22242,114,0.72 [0.42-1.23],0.2270987342849036
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,22788,249,1.27 [0.89-1.79],0.1848447038364411
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,22146,315,1.20 [0.88-1.63],0.2468379194502068
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Varicose veins,22501,378,1.15 [0.87-1.53],0.3188452097512931
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,22146,74,1.18 [0.62-2.25],0.6126942668585038
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23382,776,0.92 [0.76-1.13],0.4365015869738869
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23423,498,1.11 [0.86-1.42],0.4174121974656831
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",20298,965,1.22 [1.02-1.46],0.0289205994361585
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter V Mental and behavioural disorders,Any mental disorder,22935,3602,1.17 [1.07-1.29],0.0007341062652303
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23361,587,0.98 [0.77-1.23],0.840254365307238
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",20499,1166,1.45 [1.24-1.71],5.722302597626119e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",19418,85,1.82 [1.01-3.28],0.0460595675304583
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter V Mental and behavioural disorders,Smoking dependency,22975,1512,1.13 [0.98-1.31],0.0873901475588285
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",21186,1853,1.07 [0.93-1.22],0.3402631323086531
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter V Mental and behavioural disorders,Vascular dementia,23108,149,1.62 [1.06-2.46],0.0249934249412451
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Alzheimer disease,23615,297,1.23 [0.89-1.69],0.2018398511470311
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",15685,58,1.68 [0.83-3.43],0.1508046164913778
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Bell's palsy,22263,73,1.61 [0.85-3.03],0.1404838215842097
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22529,339,1.12 [0.83-1.51],0.4645303172575674
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Cerebral cysts,23217,236,1.30 [0.90-1.87],0.1556783546823996
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23530,364,1.39 [1.05-1.85],0.023490323031797
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,23107,60,1.13 [0.55-2.31],0.7450954013325934
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,23597,74,0.93 [0.49-1.78],0.8278305756532052
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",23073,92,1.01 [0.56-1.81],0.9844273814469912
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Epilepsy,22012,283,1.46 [1.06-2.02],0.0208988759809778
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,23086,1357,1.24 [1.07-1.43],0.0050823483069664
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,23580,678,1.08 [0.88-1.34],0.4554706919212129
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,23070,2197,1.30 [1.16-1.46],1.2011737935780482e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Generalized epilepsy,23232,60,3.00 [1.63-5.51],0.0004051336839834
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Hemiplegia,23445,279,1.50 [1.09-2.06],0.0135481732804437
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Hydrocephalus,23036,55,0.60 [0.28-1.30],0.1977554524096892
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,23598,59,1.72 [0.87-3.40],0.1169710708184129
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,22210,20,0.39 [0.11-1.39],0.1473778023983497
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,22281,91,1.52 [0.86-2.68],0.1475129735556421
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Memory loss,22946,118,1.31 [0.79-2.17],0.2994696702597668
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Migraine,21924,195,1.01 [0.67-1.51],0.9663830971760106
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23593,176,0.99 [0.65-1.52],0.9678009988673152
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Motor neuron disease,15792,152,1.55 [0.99-2.43],0.0578034689047401
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23506,61,1.18 [0.58-2.43],0.643408046484563
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",23153,963,1.13 [0.95-1.35],0.1759667312179395
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Neurological diseases,22315,3649,1.25 [1.14-1.37],2.4953026126663945e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,23287,240,1.29 [0.90-1.84],0.1642714797717374
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",22582,392,1.11 [0.83-1.46],0.4845999993372846
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",23525,351,2.13 [1.65-2.74],4.253097673300693e-09
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,18516,618,1.44 [1.15-1.80],0.0014154859249164
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,23059,78,1.15 [0.61-2.16],0.6609952572484692
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Other disorders of nervous system,23132,151,1.74 [1.13-2.68],0.0123667897375449
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,23042,140,0.93 [0.58-1.49],0.7522493178444155
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Other facial nerve disorders,22281,91,1.74 [0.99-3.04],0.0536458638395459
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Other headache syndromes,21767,38,1.58 [0.68-3.69],0.2890795369843
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Other neurological diseases,23498,517,1.31 [1.02-1.67],0.0313190953045568
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Other sleep disorders,22428,699,1.24 [1.01-1.52],0.0397720577032866
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Parkinson's disease,23594,531,1.16 [0.91-1.47],0.2303286684950705
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,23008,27,1.24 [0.42-3.66],0.6928879470256517
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Restless leg syndrome,23616,52,1.32 [0.62-2.83],0.4731016040953554
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Sleep apnoea,23316,629,1.19 [0.96-1.49],0.1094763153292378
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Small fibre neuropathy,23231,57,1.85 [0.94-3.64],0.076599576199166
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,23599,177,1.54 [1.02-2.31],0.0389164447171457
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,22223,33,0.61 [0.23-1.63],0.321408385546619
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,23615,300,1.22 [0.89-1.67],0.2218499338682763
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),23077,145,1.61 [1.05-2.46],0.0291944533065148
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,23072,86,0.73 [0.40-1.35],0.3148398674402738
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,23267,296,0.81 [0.58-1.12],0.2085878421020152
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23417,287,3.25 [2.63-4.02],1.982106558777396e-27
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,22746,44,0.80 [0.34-1.88],0.6131611716928974
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,22763,61,1.00 [0.49-2.04],0.9951570886942578
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",23523,42,2.08 [1.03-4.19],0.0403199004636536
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,23386,121,0.85 [0.51-1.42],0.5368004057913416
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2439,83,6.03 [4.34-8.37],8.99059433872123e-27
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2971,131,3.69 [2.58-5.29],1.066630933302958e-12
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,23080,94,1.42 [0.81-2.48],0.2248626614015449
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,23366,981,1.39 [1.17-1.65],0.0001926418536441
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23312,610,0.99 [0.79-1.25],0.9629985421122182
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,22845,143,0.87 [0.55-1.39],0.5732330357983813
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23538,567,0.88 [0.69-1.11],0.2788604188759512
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,23613,65,0.54 [0.27-1.09],0.0862726958499756
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,23469,498,0.79 [0.61-1.02],0.0716427367162103
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",23577,312,1.01 [0.74-1.38],0.9470146740465302
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,23526,149,1.25 [0.79-1.96],0.3395163500673741
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,22780,78,1.06 [0.56-1.98],0.8648148863899532
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,22783,81,1.00 [0.54-1.87],0.9916688804587572
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,22746,44,0.98 [0.43-2.25],0.9628919022293428
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23523,668,1.07 [0.87-1.33],0.5110662195803457
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,23037,182,1.43 [0.96-2.12],0.078423238911228
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,23000,29,1.38 [0.51-3.77],0.5301758019045275
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,23359,94,1.27 [0.72-2.23],0.4091154674443256
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,23489,224,0.93 [0.64-1.35],0.7043275618679383
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,23140,169,0.56 [0.36-0.87],0.0105034596699058
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,23460,83,0.90 [0.49-1.68],0.7496236318742782
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23305,450,0.93 [0.71-1.21],0.5719597764041602
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,23113,127,1.36 [0.85-2.19],0.2010257979744223
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,22248,1778,1.25 [1.10-1.42],0.0007227212864781
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,23458,193,0.77 [0.51-1.16],0.208885154630306
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,23602,145,1.28 [0.82-2.00],0.2814576467406267
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,23116,414,1.07 [0.81-1.40],0.6302917656486005
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,23329,64,1.21 [0.61-2.41],0.5803519860799458
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,23603,55,0.47 [0.22-1.00],0.0513437187413661
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,22778,76,0.82 [0.43-1.56],0.5392959365626152
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,22842,140,0.91 [0.57-1.46],0.6950174482470453
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,22511,126,1.47 [0.91-2.37],0.1181131446497716
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,23022,51,2.24 [1.13-4.44],0.0207745614836869
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",22449,64,0.43 [0.21-0.89],0.0223868053599607
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,22905,50,1.31 [0.60-2.84],0.4963953149045389
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",23059,204,0.92 [0.62-1.36],0.663251022219369
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,22820,118,1.70 [1.06-2.72],0.027308358260171
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,22509,124,0.93 [0.56-1.55],0.7778706994900925
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,22476,91,0.92 [0.51-1.66],0.7867076037160742
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,21930,1460,1.04 [0.90-1.20],0.596201543711484
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,22760,58,1.04 [0.50-2.14],0.9147016358078204
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23370,384,1.15 [0.86-1.52],0.3422130665642552
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,23054,68,0.73 [0.37-1.44],0.3663187100270577
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),23153,167,1.72 [1.15-2.57],0.0085969812053711
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,23441,57,1.19 [0.58-2.46],0.6322889720629703
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,23574,121,1.04 [0.63-1.73],0.8764066177288271
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,23481,114,1.54 [0.93-2.54],0.092497373948319
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,23432,48,3.17 [1.74-5.78],0.0001569274876826
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,23437,53,0.91 [0.42-1.96],0.8056734509136938
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,23521,963,1.21 [1.01-1.44],0.0368614303541042
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,23270,712,1.23 [1.00-1.51],0.0517051545289113
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,22686,128,1.30 [0.80-2.10],0.2840077733940813
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,22644,86,1.06 [0.58-1.93],0.8499120695230116
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Acute pharyngitis,23402,63,2.45 [1.32-4.54],0.0046107834836057
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23531,192,1.79 [1.23-2.61],0.0023963550677032
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,23402,63,1.70 [0.90-3.22],0.1039644410618704
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,All influenza,21341,105,2.27 [1.46-3.55],0.0002982832472178
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),21338,102,2.20 [1.39-3.50],0.0008006727676565
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Allergic asthma (mode),15480,105,0.99 [0.57-1.74],0.985527936430438
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Allergic rhinitis,23510,263,1.00 [0.71-1.41],0.991519755187911
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",16452,1416,1.21 [1.04-1.41],0.0131858046876229
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",16764,1389,1.22 [1.04-1.42],0.0118636014212226
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),23231,147,1.67 [1.08-2.59],0.0217973201553915
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",21330,94,1.45 [0.83-2.53],0.1951232546998363
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Bronchiectasis,20539,290,1.50 [1.09-2.08],0.0135094816328106
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",20294,45,1.88 [0.84-4.19],0.1223844350171131
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,22777,2528,1.22 [1.09-1.37],0.0003714209857242
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",22188,79,1.39 [0.75-2.58],0.2886550209965248
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Chronic sinusitis,22267,158,1.09 [0.70-1.71],0.6896533456178047
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23399,1292,1.31 [1.12-1.53],0.000642924721324
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Deviated nasal septum,22242,133,0.67 [0.41-1.09],0.1070747181140331
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,21623,5232,1.24 [1.15-1.34],4.322830529913629e-08
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22489,380,1.06 [0.80-1.41],0.6898119372381544
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Early onset COPD,22410,303,1.05 [0.76-1.44],0.7704676645651025
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Emphysema,20594,345,1.45 [1.08-1.96],0.0145027365754374
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22701,334,1.05 [0.77-1.42],0.7723930055243321
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,23369,2133,1.50 [1.34-1.69],4.412145843018093e-12
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Interstitial lung disease,22728,361,1.15 [0.86-1.53],0.357011649547472
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Later onset COPD,22554,989,1.36 [1.14-1.62],0.0007290208088257
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,23598,425,1.57 [1.21-2.02],0.0005749015539695
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Nasal polyp,22254,145,1.51 [0.96-2.36],0.0731285431143353
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23351,997,1.41 [1.19-1.67],7.923000330062666e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Other diseases of pleura,23339,2189,1.29 [1.15-1.45],1.949028234606484e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,22967,858,1.12 [0.92-1.35],0.259065936171143
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Other pleural conditions,21214,64,0.89 [0.44-1.80],0.7388728625213865
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23523,444,1.45 [1.13-1.87],0.0040053266983687
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23495,1388,1.27 [1.10-1.47],0.0014660809531096
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Pleural effusion,22269,1119,1.51 [1.29-1.77],3.906745620582072e-07
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Pleural plaque,21413,263,1.15 [0.82-1.61],0.4291314687467102
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",23106,1870,1.55 [1.38-1.76],1.704918708124668e-12
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,23500,327,1.75 [1.31-2.34],0.0001328800776855
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Pneumothorax,21287,137,1.20 [0.75-1.93],0.451771370466438
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Pollen allergy,23602,229,0.98 [0.68-1.43],0.9301750410451484
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Pulmonary oedema,23146,67,3.80 [2.56-5.64],3.7873595022432985e-11
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Respiratory insufficiency,15431,56,0.87 [0.40-1.86],0.7132708249125133
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23333,979,1.44 [1.21-1.70],3.421228483156136e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,22374,265,1.01 [0.72-1.43],0.9512722997322676
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Viral pneumonia,21513,277,1.31 [0.95-1.81],0.1030334889362141
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",23250,237,1.16 [0.82-1.66],0.4014273368627844
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,10295,111,1.30 [0.75-2.25],0.3432502628677142
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,16479,88,1.27 [0.70-2.32],0.4275346616606559
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Acute appendicitis,23481,145,0.95 [0.59-1.51],0.8156658262480179
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Acute gastritis,17846,89,1.93 [1.14-3.27],0.0149359171519786
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Acute pancreatitis,22275,201,1.40 [0.96-2.05],0.0806826469200015
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Acute peritonitis,23255,99,2.60 [1.69-4.03],1.641047774619154e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Alcoholic liver disease,22728,115,2.65 [1.72-4.07],9.104393450353269e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Barrett oesophagus,18280,523,1.45 [1.14-1.83],0.0022319221884917
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",22194,120,1.10 [0.66-1.82],0.7163435987627412
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",23213,120,1.07 [0.65-1.77],0.7915422666024013
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Cholecystitis,22293,219,1.16 [0.80-1.68],0.4340501324071808
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Cholelithiasis,22854,780,1.54 [1.28-1.87],6.633698412969194e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Chronic gastritis,18019,262,1.64 [1.18-2.27],0.003057040803906
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Chronic pancreatitis,22131,57,2.23 [1.17-4.25],0.0152064058369229
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",23409,133,3.06 [2.24-4.18],2.261788425198056e-12
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Coeliac disease,22007,90,2.67 [1.62-4.40],0.000114671656514
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Collagenous colitis,22191,49,0.81 [0.36-1.81],0.6051036451671077
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23453,219,1.10 [0.76-1.60],0.619958332056854
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Constipation,23452,1581,1.29 [1.13-1.49],0.0002508914502716
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Crohn disease,22232,90,1.20 [0.67-2.16],0.5366688057783415
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23275,65,1.31 [0.66-2.59],0.4329904503267165
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,22218,76,1.50 [0.80-2.80],0.2028306205027416
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Dental caries,22980,227,1.14 [0.79-1.64],0.4912879547222596
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,20004,1930,1.37 [1.21-1.55],8.197537755546449e-07
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Diseases of appendix,23513,177,1.03 [0.68-1.57],0.8844143391374562
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Diseases of liver,23476,863,1.54 [1.29-1.85],2.8204126805234977e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",21647,3890,1.30 [1.19-1.42],3.559869413154477e-09
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23263,510,1.27 [0.99-1.61],0.0581437334911296
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23567,411,1.34 [1.02-1.75],0.0323871791840326
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22863,110,0.93 [0.54-1.59],0.7901249632361241
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Diseases of salivary glands,22721,65,1.57 [0.80-3.08],0.1886136477429559
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,23306,1389,1.45 [1.25-1.67],5.652068508385116e-07
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Diseases of tongue,22741,106,1.47 [0.87-2.48],0.1500893531047745
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",23253,1179,1.41 [1.20-1.64],2.1286287122681363e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,19423,3032,1.13 [1.02-1.26],0.0180950117872819
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Duodenal ulcer,18021,264,1.45 [1.04-2.02],0.0272694836829786
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23501,207,1.29 [0.88-1.89],0.1857287857474063
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23544,47,0.68 [0.30-1.56],0.3677000406864402
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,22769,156,2.89 [2.13-3.92],8.828120639650012e-12
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,16571,180,1.16 [0.76-1.77],0.4777249611807491
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Functional dyspepsia,18170,413,1.07 [0.81-1.41],0.6283588440980148
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Gastric ulcer,18118,361,1.37 [1.03-1.81],0.0297210784213416
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,19885,2128,1.22 [1.08-1.38],0.0010763993125874
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,18347,590,1.40 [1.12-1.75],0.0027427187184767
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,18062,7919,1.20 [1.13-1.28],1.8580144926766883e-08
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,GI-bleeding,23075,1158,1.42 [1.21-1.67],1.2886364599285482e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,22798,45,1.95 [0.90-4.22],0.0913876987809788
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,17343,1218,1.12 [0.95-1.32],0.1688992797651518
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",22697,84,2.75 [1.74-4.33],1.3596579760797062e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Hernia,21581,3507,1.23 [1.12-1.35],1.943198385258656e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Impacted teeth,23547,44,0.63 [0.27-1.49],0.2959846494461713
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Impaction of intestines,16438,47,2.58 [1.15-5.78],0.0213172589715126
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Inguinal hernia,19688,1614,1.08 [0.94-1.24],0.2835450835559707
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",18270,196,0.88 [0.59-1.32],0.5430090019928087
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,16478,87,1.02 [0.55-1.88],0.9458042426673082
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,22020,103,2.55 [1.58-4.09],0.0001130423036729
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,16661,270,1.23 [0.87-1.74],0.2373374254632001
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,23575,376,1.31 [0.99-1.73],0.0586754145719722
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22815,673,1.47 [1.19-1.81],0.0002842608482871
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,23020,878,1.37 [1.14-1.65],0.0007050256479966
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,17970,213,1.47 [1.01-2.13],0.0421803334839041
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Oesophagitis,18374,617,1.34 [1.07-1.67],0.0094673440358284
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23565,114,1.23 [0.73-2.07],0.4284921758795657
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,18149,75,2.00 [1.10-3.64],0.0228071776646793
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,17818,1427,1.24 [1.07-1.44],0.0052233159112701
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,22330,256,1.06 [0.74-1.50],0.761970249793991
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,22195,121,1.34 [0.82-2.21],0.2429283183426941
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other diseases of intestine,18260,1869,1.18 [1.03-1.34],0.0152816796425941
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other diseases of intestines,21819,5428,1.19 [1.10-1.29],7.473745197621176e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22705,181,1.44 [0.96-2.16],0.0758657121327918
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other diseases of liver,23302,689,1.51 [1.23-1.85],6.656999166438728e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,18488,731,1.58 [1.30-1.92],5.922272411227488e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other diseases of pancreas,22217,143,2.29 [1.56-3.37],2.490485866727091e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23495,339,1.02 [0.76-1.38],0.884789133352359
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,18552,795,1.78 [1.48-2.13],4.80657860776424e-10
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,23086,1169,1.43 [1.22-1.67],8.79013786782549e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22931,178,1.37 [0.91-2.06],0.1309170213680865
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,18009,1618,1.34 [1.17-1.54],4.007374276843512e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),19599,1842,1.47 [1.30-1.67],1.922720074621173e-09
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,22710,97,2.37 [1.52-3.71],0.0001564466346201
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,22913,771,1.47 [1.21-1.78],0.0001124005348336
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",16736,345,1.48 [1.09-2.00],0.0121089790539245
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23536,55,0.78 [0.37-1.68],0.5339841226050923
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,16861,470,1.52 [1.18-1.98],0.0014894880695898
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22079,162,1.38 [0.90-2.12],0.1362639581622216
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Recurring oral aphthae,23602,44,2.30 [1.12-4.72],0.0231802485464151
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,22762,107,1.79 [1.08-2.97],0.0249914405340576
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Toxic colitis,22187,45,1.64 [0.77-3.52],0.2019336236906447
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,18052,295,1.15 [0.83-1.59],0.3969332495087391
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Ulcerative colitis,22288,146,1.29 [0.82-2.04],0.2763672394744131
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",22264,122,1.08 [0.65-1.81],0.7553546443234667
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Umbilical hernia,18444,370,1.43 [1.08-1.90],0.0133171030831084
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,16545,154,1.77 [1.12-2.79],0.0138522574718995
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Ventral hernia,18331,257,1.53 [1.09-2.14],0.0145401497320156
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Volvulus,16464,73,1.32 [0.68-2.57],0.4156722196699253
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,23541,327,0.88 [0.65-1.21],0.4365761601319893
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,23300,68,1.61 [0.85-3.06],0.1459892347071437
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,21647,93,1.54 [0.88-2.72],0.1339595686109412
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,22888,758,1.57 [1.30-1.90],3.669848188548785e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",22329,199,1.55 [1.05-2.28],0.0257948888568458
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,22020,466,1.74 [1.37-2.21],4.9281297053232286e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,23326,267,1.08 [0.77-1.51],0.674426798378222
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23529,470,1.13 [0.88-1.46],0.3463506309584833
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,23102,43,1.32 [0.57-3.03],0.5169800842515961
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,22148,3148,1.22 [1.11-1.35],7.505394441439787e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23175,406,1.01 [0.76-1.33],0.95588725677091
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,23062,293,1.01 [0.73-1.40],0.9576475942777432
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23153,1023,1.51 [1.27-1.78],1.5006429604521914e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",23606,30,0.98 [0.36-2.70],0.9735957612992756
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,21577,23,2.80 [1.02-7.66],0.0447381051898144
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,22827,58,0.79 [0.38-1.64],0.5272873740365589
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,23321,262,1.05 [0.75-1.48],0.7682853373566181
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,22032,478,1.14 [0.88-1.47],0.3287191529288726
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,21632,78,0.90 [0.48-1.72],0.7579055011441821
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,23549,82,2.02 [1.16-3.51],0.013253179255516
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,22339,209,1.63 [1.14-2.34],0.0076421491857213
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23447,215,0.72 [0.49-1.06],0.0930384260229319
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,23131,72,1.05 [0.55-2.01],0.8765200180285528
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,21619,65,0.62 [0.30-1.26],0.1841226491202826
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,23167,1613,1.38 [1.20-1.58],3.73561613345954e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",22073,519,1.22 [0.95-1.55],0.1177065085244192
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,21635,81,1.00 [0.53-1.87],0.9955755532754972
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23528,296,0.84 [0.60-1.16],0.2924085299227602
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,23114,55,2.13 [1.11-4.07],0.0228461571876294
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23491,259,0.84 [0.59-1.19],0.3201279659381767
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23561,347,0.89 [0.66-1.21],0.4575561738297813
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,21640,86,1.48 [0.82-2.68],0.1940629462540293
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,21819,265,0.81 [0.57-1.15],0.2343359748232845
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23554,340,0.91 [0.67-1.24],0.564789537748402
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",21820,266,2.05 [1.56-2.70],3.304752693611448e-07
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,23590,123,1.69 [1.06-2.72],0.0290432351636015
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,20387,92,1.61 [0.93-2.78],0.0862371808107408
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,21542,4732,1.12 [1.03-1.21],0.0066633302142195
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,20144,3334,1.10 [1.00-1.21],0.049055320879459
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,20367,72,1.27 [0.66-2.44],0.4700615629673967
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,20723,149,1.35 [0.86-2.13],0.1921692105386456
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,20714,140,1.98 [1.26-3.10],0.0028207943651694
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,23412,68,1.33 [0.68-2.59],0.4004844967801502
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",20651,77,1.72 [0.92-3.20],0.0897453641924881
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,17672,862,0.96 [0.79-1.17],0.6858389192720817
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23500,148,0.93 [0.59-1.48],0.7709231577969232
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,20841,267,0.99 [0.70-1.40],0.9604433964638248
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,20093,6210,1.08 [1.01-1.16],0.0262508546810327
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,22561,91,2.12 [1.25-3.58],0.0052593135235576
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,20461,166,1.25 [0.82-1.92],0.3022777117962613
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,20729,434,1.04 [0.79-1.35],0.8013868119589962
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,22805,2231,1.08 [0.96-1.22],0.1790670916824048
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20655,360,0.96 [0.71-1.29],0.7780465212301722
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,20345,50,1.58 [0.74-3.37],0.2375744668561268
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20389,94,0.85 [0.47-1.52],0.5771409990927607
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,23301,29,0.35 [0.12-1.00],0.0505905787026126
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,18260,1450,1.24 [1.07-1.43],0.004012473651287
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,17779,969,1.50 [1.26-1.78],4.380230822714615e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23480,957,1.42 [1.20-1.68],5.8300080990046335e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,16858,48,0.40 [0.18-0.90],0.0276392917117082
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),16889,79,1.63 [0.90-2.96],0.1083744619260505
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,20565,270,0.90 [0.64-1.27],0.558891866188341
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,17431,621,1.22 [0.97-1.52],0.0844464625130309
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,20614,40,1.17 [0.48-2.85],0.7284829757867626
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,21103,529,1.15 [0.90-1.47],0.2537812075040009
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,20843,269,1.15 [0.81-1.61],0.4342330023755583
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,17393,583,1.22 [0.97-1.54],0.085633033568919
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,20361,66,1.08 [0.54-2.13],0.8315223992343306
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",20349,54,1.23 [0.58-2.62],0.5823211926488229
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,22562,92,2.21 [1.39-3.54],0.0008776070062649
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,23328,858,1.25 [1.03-1.50],0.0212431563640925
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,22869,399,1.07 [0.81-1.42],0.6176672015321238
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23535,285,1.58 [1.16-2.16],0.003733775839881
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,18674,1864,1.18 [1.04-1.34],0.0122282839357366
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,16862,52,0.98 [0.45-2.16],0.968343986071686
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,20378,83,1.36 [0.74-2.50],0.3168213036649208
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,16865,55,1.38 [0.66-2.87],0.3939522614516104
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),16855,45,2.01 [0.93-4.36],0.0772597829095913
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,22656,186,1.19 [0.79-1.79],0.3960534245293479
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,22631,161,1.15 [0.74-1.77],0.5410278062340942
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,23582,86,1.26 [0.70-2.29],0.438867268220814
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",22102,1528,1.10 [0.96-1.27],0.179654507353199
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,20362,67,2.01 [1.07-3.81],0.0312388230291935
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),16850,40,2.00 [0.90-4.47],0.0904777601023682
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,21190,616,1.13 [0.90-1.42],0.2872225360555789
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,18503,1693,1.21 [1.06-1.39],0.0055678206538102
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,23326,54,0.83 [0.39-1.79],0.6356829046143104
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,23599,62,1.82 [0.94-3.51],0.0733936950510068
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,20375,80,0.88 [0.47-1.64],0.677616744188291
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",21273,978,1.35 [1.13-1.60],0.0007537460701962
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,20390,95,1.07 [0.61-1.90],0.8060165675828547
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,18010,1200,1.15 [0.98-1.35],0.0780294655104322
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,22555,85,0.92 [0.50-1.69],0.7869275348795133
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,20339,44,0.85 [0.36-1.99],0.7010901322839834
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,20685,111,0.77 [0.45-1.32],0.343528077397
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,20795,500,1.23 [0.97-1.57],0.0908892574470672
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23463,191,1.23 [0.83-1.83],0.2988794262724649
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,21058,484,1.13 [0.88-1.46],0.3296273831380998
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23544,280,1.59 [1.16-2.18],0.0036403052070767
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,23601,37,1.24 [0.50-3.06],0.6359491142555043
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20444,149,1.31 [0.84-2.05],0.2398143975823925
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,19351,570,1.53 [1.23-1.92],0.0001674056702359
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,20778,483,1.46 [1.15-1.86],0.0020032733413414
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20620,325,0.85 [0.62-1.16],0.2958395154634863
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",16840,30,0.93 [0.33-2.59],0.8863482899234005
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,19062,2252,1.27 [1.13-1.42],6.939852659270658e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,17254,444,1.45 [1.13-1.86],0.0039856865540021
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,23434,162,1.06 [0.69-1.63],0.7970775875678034
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",23543,47,1.99 [0.95-4.13],0.066312068960842
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",21648,45,2.31 [1.10-4.86],0.02783949573344
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,16874,64,1.90 [0.99-3.65],0.0531072688366924
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,20662,88,0.74 [0.41-1.36],0.3342337285930303
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,17102,292,1.65 [1.21-2.25],0.0015510142333977
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,20568,273,1.00 [0.71-1.41],0.9914915487408495
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,20788,214,0.91 [0.62-1.33],0.6193626615590518
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,20665,91,1.32 [0.74-2.35],0.3521502623487719
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,18751,29,2.56 [1.03-6.37],0.0432056396529158
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",23603,39,1.31 [0.55-3.13],0.5476354150516035
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,20821,526,1.05 [0.82-1.33],0.7184187890627872
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],23290,18,2.11 [0.66-6.71],0.2056514255437996
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,22552,2257,1.19 [1.06-1.33],0.0037671781278396
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20398,103,0.93 [0.54-1.63],0.8095878978097779
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,21076,502,1.14 [0.89-1.47],0.2831763916591311
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,22570,196,0.69 [0.46-1.04],0.0761759547008597
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,20703,129,0.90 [0.55-1.48],0.6870320603648401
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,21881,1307,1.18 [1.01-1.38],0.0343502262648306
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,21391,817,1.35 [1.12-1.64],0.0019416406899255
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],20338,43,1.58 [0.69-3.61],0.2789546409377331
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,23311,39,2.58 [1.19-5.58],0.0163290089398978
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20415,120,1.15 [0.69-1.89],0.5943739837471838
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,20317,22,0.82 [0.25-2.71],0.7489257339962627
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),16870,60,2.20 [1.14-4.22],0.0184467936459622
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,22616,1857,2.21 [1.95-2.50],3.416130927070283e-36
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23151,403,0.98 [0.74-1.30],0.892797681210834
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,22887,139,0.74 [0.46-1.19],0.2161616769594328
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,22291,1532,2.97 [2.64-3.33],2.0768654642827287e-75
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,23360,85,3.78 [2.73-5.22],8.407337053334495e-16
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,23339,359,1.13 [0.85-1.51],0.4036441775631724
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Cystitis,20771,212,1.78 [1.25-2.54],0.0014186680918901
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Dialysis,20866,107,9.02 [6.66-12.23],1.1007764169043425e-45
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,22345,3304,1.10 [1.00-1.21],0.0560282360888587
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,21260,5545,1.35 [1.25-1.46],4.638740875523501e-15
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,23378,103,4.89 [3.77-6.35],6.341393307958527e-33
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Hydrocele,19247,206,1.01 [0.68-1.50],0.9508018294256166
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,20865,365,1.50 [1.12-2.02],0.0063804078672118
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,21631,2590,1.14 [1.02-1.28],0.0164331764989038
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),19273,232,0.90 [0.62-1.30],0.5672302555978631
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,20637,78,1.80 [1.00-3.23],0.0494291906205503
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,19150,109,0.81 [0.47-1.40],0.4562148217067377
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",23604,61,1.57 [0.80-3.09],0.1868077432597779
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",23609,58,2.45 [1.29-4.67],0.0063307460317625
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,22794,2235,1.35 [1.20-1.51],3.240662513446834e-07
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,21501,942,1.24 [1.03-1.48],0.0199410741236674
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23544,564,1.40 [1.12-1.76],0.0032850399068287
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,19351,310,1.33 [0.97-1.83],0.0736341986264463
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,19321,280,1.18 [0.85-1.65],0.3297937165956396
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,19271,230,0.86 [0.59-1.25],0.4351520207315704
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,23599,47,1.51 [0.69-3.29],0.2980846826788921
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,22086,1527,1.43 [1.24-1.63],3.196474819991205e-07
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,20909,409,1.50 [1.14-1.97],0.003905243808153
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,23170,190,1.55 [1.05-2.29],0.0263806212045435
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,23334,59,3.32 [1.99-5.53],4.242653546084254e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",19303,262,1.05 [0.75-1.49],0.7648778203655876
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,23313,2813,2.08 [1.89-2.30],4.0877138280206456e-48
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",20570,70,2.85 [1.54-5.27],0.0008574266965218
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,20917,158,4.19 [2.87-6.12],1.1035791511275833e-13
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,22823,75,0.97 [0.51-1.86],0.9376348642818216
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,20854,295,1.16 [0.84-1.60],0.3561700690554653
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23266,518,0.98 [0.77-1.26],0.889094998422826
